NMTC
NASDAQ
US
NeuroOne Medical Technologies Corporation - Common Stock
$0.80
▼ $-0.01
(-0.87%)
Vol 111K
6
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$38.2M
ROE
-163.1%
Margin
-55.4%
D/E
12.71
Beta
0.69
52W
$0–$1
Wall Street Consensus
9 analysts · Apr 20263
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
88.9%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 100.0%
Next Report
May 11, 2026
EPS Estimate: $-0.04
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Jun 2026 | $-0.04 | — | — |
| Dec 2025 | $-0.04 | $-0.03 | +$0.01 |
| Sep 2025 | $-0.04 | $-0.04 | +$0.00 |
| Jun 2025 | $-0.05 | $-0.03 | +$0.02 |
Quarterly Revenue & Earnings
| Quarter | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Revenue | $3.3M | $1.4M | $1.7M | $2.7M | $2.9M |
| Net Income | $1.8M | -$2.3M | -$1.5M | -$1.6M | -$1.4M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -163.1% | -334.8% | -163.5% | -163.5% | -163.5% | -163.1% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -88.4% | -75.4% | -55.4% | -55.4% | -55.4% | -55.4% |
| Gross Margin | 53.9% | 69.9% | 70.1% | 70.1% | 70.1% | 70.1% |
| D/E Ratio | 12.71 | 120.84 | 12.73 | 12.73 | 12.73 | 12.71 |
| Current Ratio | 6.99 | 2.13 | 7.13 | 7.13 | 7.13 | 6.99 |
Key Ratios
ROA (TTM)
-78.0%
P/S (TTM)
3.97
P/B
37.2
EPS (TTM)
$-0.16
CF/Share
$-0.60
Rev Growth 3Y
+143.2%
52W High
$1.39
52W Low
$0.40
$0.40
52-Week Range
$1.39
Financial Health
Free Cash Flow
-$3.2M
Net Debt
-$3.3M
Cash
$3.6M
Total Debt
$237K
As of Dec 31, 2025
How does NMTC compare to Health Care peers?
Peer group: Micro-cap Health Care (All) · 241 companies
NMTC valuation vs Health Care peers
P/E ratio
—
▼
0%
below
peers
(30.7)
vs Peers
vs Industry
Undervalued
P/S ratio
4.0
▲
54%
above
peers
(2.6)
vs Peers
vs Industry
Pricier
P/B ratio
37.2
▲
1238%
above
peers
(2.8)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.7%)
vs Peers
vs Industry
Low yield
NMTC profitability vs Health Care peers
ROE
-163.1%
▼
324%
below
peers
(-38.5%)
vs Peers
vs Industry
Weak
Net margin
-55.4%
▼
124%
below
peers
(-24.7%)
vs Peers
vs Industry
Weak
Gross margin
70.1%
▲
33%
above
peers
(52.9%)
vs Peers
vs Industry
Top tier
ROA
-78.0%
▼
268%
below
peers
(-21.2%)
vs Peers
vs Industry
Weak
NMTC financial health vs Health Care peers
D/E ratio
12.7
▼
34%
below
peers
(19.3)
vs Peers
vs Industry
Above avg
Current ratio
7.0
▲
224%
above
peers
(2.2)
vs Peers
vs Industry
Strong liquidity
Beta
0.7
▼
34%
below
peers
(1.1)
vs Peers
vs Industry
More volatile
NMTC fundamentals radar
NMTC
Peer median
Industry
NMTC profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
NMTC vs peers: key metrics
Latest News
No related news yet